From there, your doctor may increase your dose by 2.5 mg increments every month, depending on your treatment goals and how your body responds
CrossRef 12,806 View 742 Download 16 Web of Science Crossref Snapshot Steatotic liver disease PDF Citations Citations to this article as recorded by Efruxifermin in patients with metabolic dysfunction-associated steatohepatitis: A GRADE-assessed systematic review and meta-analysis Umama Alam, Shree Rath, Muhammad Ansab, Aamna Kashif, Furqan Ahmad Sethi, Hafiza Tooba Siddiqui, Zarar Ahmad Khan Afridi, Muhammad Burhan, Muhammad Abdullah Ali, Abdul Moiz, Zaryab Bacha, Ahmad Khan, Raheel Ahmed, Monsurah Bisola Alatise, Kamil Ahmad Kami World Journal of Hepatology .2026;[Epub] CrossRef Engineering Murine CrossReactivity Into an Affibody to Human Death Receptor 5 TseHan Kuo, Nagamani Vunnam, Jonathan N
+ The 50mg vial suits standard research protocols and shorter studies
Proepicate is a novel patented compound based on a natural plant flavonoid